In our analysis, the hazard risk of all clinical events except HCC was 20–80 times higher in the low albumin group than in the high albumin group by Cox proportional hazard regression analysis (Figure 2); these results are consistent with those of previous reports. This evidence concerns the gene ALB and hepatocellular carcinoma.